Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 656-663
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.656
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.656
Figure 1 Process of treatment decision in lung cancer.
After referral of patients’ lung function tests, blood samples, computed tomography scans, and star climbing tests are reviewed in multidiscipline team (MDT) and the diagnostic plan formed, after which doctor's visit and defined examinations. Treatment decision including operation, radiotherapy and systemic therapy by MDT planning meeting is based on performance status, stage and histology. PET: Positron emission tomography; CT: Computed tomography; EBUS: Endobronchial ultrasound; MDT: Multidiscipline team.
- Citation: Saarenheimo J, Andersen H, Eigeliene N, Jekunen AP. Current challenges in applying gene-driven therapies in clinical lung cancer practice. World J Clin Oncol 2021; 12(8): 656-663
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/656.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.656